Received Mar 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | LN0588 | IM / LA |
Systemic: Neurological Disorder (diagnosed by MD)-Severe, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Weakness-Medium, Additional Details: Guillain-Barré syndrome (severe muscle weakness) was observed after vaccination. Patient reported still having a lot of weakness and still needs assistance walking., Other Vaccines: VaccineTypeBrand: FLUZONE HIGH-DOSE TRI-VALENT; Manufacturer: SANOFI; LotNumber: UT8419BA; Route: INTRAMUSCULAR; BodySite: LEFT ARM; Dose: 1; VaxDate: 10/23/2024